These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10103095

  • 1. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal.
    Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL.
    Eur J Neurosci; 1999 Mar; 11(3):1037-41. PubMed ID: 10103095
    [Abstract] [Full Text] [Related]

  • 2. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.
    Diana M, Pistis M, Muntoni A, Gessa G.
    J Pharmacol Exp Ther; 1995 Feb; 272(2):781-5. PubMed ID: 7853194
    [Abstract] [Full Text] [Related]

  • 3. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors.
    Georges F, Aston-Jones G.
    Neuropsychopharmacology; 2003 Jun; 28(6):1140-9. PubMed ID: 12700697
    [Abstract] [Full Text] [Related]

  • 4. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.
    Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL.
    Proc Natl Acad Sci U S A; 1993 Sep 01; 90(17):7966-9. PubMed ID: 8367449
    [Abstract] [Full Text] [Related]

  • 5. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
    Spanagel R, Almeida OF, Bartl C, Shippenberg TS.
    Psychopharmacology (Berl); 1994 Jun 01; 115(1-2):121-7. PubMed ID: 7862883
    [Abstract] [Full Text] [Related]

  • 6. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal.
    Gobbi G, Muntoni AL, Gessa GL, Diana M.
    Psychopharmacology (Berl); 2001 Oct 01; 158(1):1-6. PubMed ID: 11685378
    [Abstract] [Full Text] [Related]

  • 7. Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates.
    Espejo EF, Serrano MI, Caillé S, Stinus L.
    Neuropsychopharmacology; 2001 Aug 01; 25(2):204-12. PubMed ID: 11425504
    [Abstract] [Full Text] [Related]

  • 8. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.
    Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA, Chartoff EH.
    J Neurosci; 2016 May 25; 36(21):5748-62. PubMed ID: 27225765
    [Abstract] [Full Text] [Related]

  • 9. Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).
    Almela P, Navarro-Zaragoza J, García-Carmona JA, Mora L, Hidalgo J, Milanés MV, Laorden ML.
    PLoS One; 2012 May 25; 7(10):e47089. PubMed ID: 23071721
    [Abstract] [Full Text] [Related]

  • 10. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
    Schoffelmeer AN, Wardeh G, Vanderschuren LJ.
    Synapse; 2001 Nov 25; 42(2):87-94. PubMed ID: 11574945
    [Abstract] [Full Text] [Related]

  • 11. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons.
    Bull PM, Ludwig M, Blackburn-Munro GJ, Delgado-Cohen H, Brown CH, Russell JA.
    Eur J Neurosci; 2003 Nov 25; 18(9):2545-51. PubMed ID: 14622155
    [Abstract] [Full Text] [Related]

  • 12. No effect of morphine on ventral tegmental dopamine neurons during withdrawal.
    Georges F, Le Moine C, Aston-Jones G.
    J Neurosci; 2006 May 24; 26(21):5720-6. PubMed ID: 16723528
    [Abstract] [Full Text] [Related]

  • 13. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.
    Diana M, Pistis M, Muntoni A, Gessa G.
    Neuroscience; 1996 Mar 24; 71(2):411-5. PubMed ID: 9053796
    [Abstract] [Full Text] [Related]

  • 14. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal.
    García-Pérez D, Núñez C, Laorden ML, Milanés MV.
    Addict Biol; 2016 Mar 24; 21(2):374-86. PubMed ID: 25522207
    [Abstract] [Full Text] [Related]

  • 15. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.
    Ghosh S, Grasing K.
    Neurochem Res; 1999 Jan 24; 24(1):95-107. PubMed ID: 9973242
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
    Navarro-Zaragoza J, Laorden ML, Milanés MV.
    Addict Biol; 2017 Mar 24; 22(2):342-353. PubMed ID: 26598419
    [Abstract] [Full Text] [Related]

  • 17. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference.
    He S, Li N, Grasing K.
    Pharmacol Biochem Behav; 2004 Feb 24; 77(2):327-35. PubMed ID: 14751461
    [Abstract] [Full Text] [Related]

  • 18. Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist.
    Walters CL, Aston-Jones G, Druhan JP.
    Neuropsychopharmacology; 2000 Sep 24; 23(3):307-15. PubMed ID: 10942854
    [Abstract] [Full Text] [Related]

  • 19. Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens.
    Ghosh S, Patel AH, Cousins M, Grasing K.
    Neurochem Res; 1998 Jun 24; 23(6):875-85. PubMed ID: 9572677
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.
    Cadoni C, Di Chiara G.
    Neuroscience; 1999 May 24; 90(2):447-55. PubMed ID: 10215150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.